Three recent studies report cryo-EM structures of amyloid fibrils of islet amyloid polypeptide (IAPP), which are linked to type 2 diabetes (T2D) pathogenesis. The results shed light on the structural basis of IAPP fibril formation, reveal remarkable similarities between IAPP and Aβ fibrils and will inform the design of anti-amyloid drugs in T2D and Alzheimer’s disease (AD).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly
Nature Communications Open Access 25 August 2022
-
Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin
Nature Communications Open Access 02 May 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Opie, E. L. J. Exp. Med. 5, 397–428 (1901).
Westermark, P., Andersson, A. & Westermark, G. T. Physiol. Rev. 91, 795–826 (2011).
Jackson, K. et al. Ann. Neurol. 74, 517–526 (2013).
Moreno-Gonzalez, I. et al. Mol. Psychiatry 22, 1327–1334 (2017).
OʼNuallain, B., Williams, A. D., Westermark, P. & Wetzel, R. J. Biol. Chem. 279, 17490–17499 (2004).
Oskarsson, M. E. et al. Am. J. Pathol. 185, 834–846 (2015).
Yan, L.-M., Velkova, A., Tatarek-Nossol, M., Andreetto, E. & Kapurniotu, A. Angew. Chem. Int. Ed. Engl. 46, 1246–1252 (2007).
Röder, C. et al. Nat. Struct. Mol. Biol. 27, 660–667 (2020).
Cao, Q., Boyer, D. R., Sawaya, M. R., Ge, P. & Eisenberg, D. S. Nat. Struct. Mol. Biol. 27, 653–659 (2020).
Gallardo, R. et al. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-020-0496-3 (2020).
Westermark, P., Wernstedt, C., Wilander, E. & Sletten, K. Biochem. Biophys. Res. Commun. 140, 827–831 (1986).
Andreetto, E. et al. Angew. Chem. Int. Ed. Engl. 49, 3081–3085 (2010).
Yan, L.-M., Velkova, A. & Kapurniotu, A. Curr. Pharm. Des. 20, 1182–1191 (2014).
Akter, K. et al. Br. J. Clin. Pharmacol. 71, 365–376 (2011).
Luca, S., Yau, W.-M., Leapman, R. & Tycko, R. Biochemistry 46, 13505–13522 (2007).
Wiltzius, J. J. W. et al. Protein Sci. 17, 1467–1474 (2008).
Weirich, F. et al. PLoS ONE 11, e0161243 (2016).
Kajava, A. V., Aebi, U. & Steven, A. C. J. Mol. Biol. 348, 247–252 (2005).
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T. & Betsholz, C. Proc. Natl Acad. Sci. USA 87, 5036–5040 (1990).
Tenidis, K. et al. J. Mol. Biol. 295, 1055–1071 (2000).
Buchanan, L. E. et al. Proc. Natl Acad. Sci. USA 110, 19285–19290 (2013).
Ashburn, T. T., Auger, M. & Lansbury, P. T. Jr. J. Am. Chem. Soc. 114, 790–791 (1992).
Yan, L.-M., Tatarek-Nossol, M., Velkova, A., Kazantzis, A. & Kapurniotu, A. Proc. Natl Acad. Sci. USA 103, 2046–2051 (2006).
Armiento, V., Spanopoulou, A. & Kapurniotu, A. Angew. Chem. Int. Ed. Engl. 59, 3372–3384 (2020).
Petkova, A. T. et al. Proc. Natl Acad. Sci. USA 99, 16742–16747 (2002).
Luo, J., Wärmländer, S. K. T. S., Gräslund, A. & Abrahams, J. P. J. Biol. Chem. 291, 16485–16493 (2016).
Horvath, I. & Wittung-Stafshede, P. Proc. Natl Acad. Sci. USA 113, 12473–12477 (2016).
Gremer, L. et al. Science 358, 116–119 (2017).
Acknowledgements
Financial support by the Deutsche Forschungsgemeinschaft (SFB 1035; B06) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author is a coinventor on patents and patent applications for designed peptides as inhibitors of IAPP and Aβ amyloid formation and their use in the treatment of T2D and AD.
Rights and permissions
About this article
Cite this article
Kapurniotu, A. Enlightening amyloid fibrils linked to type 2 diabetes and cross-interactions with Aβ. Nat Struct Mol Biol 27, 1006–1008 (2020). https://doi.org/10.1038/s41594-020-00523-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41594-020-00523-z
This article is cited by
-
Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin
Nature Communications (2022)
-
Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly
Nature Communications (2022)